Only the three programs above passed all four
A recent report found that of 125,474 patients initiating GLP-1 RAs, 46.5% of patients with and 64.8% without type 2 diabetes discontinued medication within 1 year
Journal reference: Corrao S, Pollicino C, Maggio D, Torres A and Argano C (2024) Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence
This dehydration can cause kidney problems, sometimes requiring hemodialysis
Common Mental Health Side Effects: What the Evidence Shows Clinical trials of tirzepatide report anxiety, nervousness, or mood swings in fewer than 5% of users, placing these symptoms in the uncommon category
Interest in peptide treatments has grown significantly in recent years as people explore ways to improve recovery, support anti-aging, enhance metabolism, and optimize physical performance